Dr. Edward Williams Holt, MD

Dr. Holt practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Holt's NPI, 1891816369, was assigned on April 3, 2007. Dr. Holt graduated from Medical University of South Carolina (MUSC) in 2005. Dr. Holt holds California license 883185.

Dr. Holt's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Holt's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Holt is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Holt to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holt practices, 7 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Holt's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Holt is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Holt's licenses on file in 3 states: California, Hawaii and Massachusetts.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c and upper GI endoscopy among the conditions Dr. Holt treats.

CMS data shows 566 Medicare services from Dr. Holt across 6 procedure codes in 2024, for 278 Medicare patients. Medicare paid $65,206 for them.

CMS counts 278 Medicare patients who saw Dr. Holt in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Holt's median patient age at 63, with 46% women.

In 2024, Dr. Holt wrote 1,006 Medicare Part D claims for 134 patients. 78% of them were for generic drugs. CMS names the drug for 823 of them, across 21 drugs with 11 or more claims each, at $882,187 in total drug cost. In 2023, CMS named 730 claims across 17 drugs.

Dr. Holt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holt as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Holt, published from 2012 to 2019. 2012 was the busiest year, with 2. The most frequent topics are Colonoscopy, Carcinoma, Hepatocellular and Cathartics. Dr. Holt has published most often in Dig Dis Sci. Dr. Holt's most frequent co-authors are Michael S. Verhille, MD, Kidist Kidane Yimam, MD and Taft P. Bhuket, MD.

CMS Open Payments shows 7 general payments to Dr. Holt from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 96% of the total. Gilead Sciences, Inc. paid the most, $4,940.

Dr. Holt graduated from Medical University of South Carolina (MUSC) in 2005.

Dr. Holt is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.